X. Li, J. He, and C. Song, “Research Progress on the CDK4/6 Signaling Pathway and Clinical Application of Its Inhibitors in HR+/HER2- Breast Cancer”, Health Nexus, vol. 1, pp. 31–37, Nov. 2025, doi: 10.63802/healthnexus.V1.2025.148.